Radiation oncology firm Nucletron of Veenendaal, the Netherlands, enjoyed strong financial results over the first half of 2010.
Net sales amounted to 57 million euros ($72.6 million U.S.), an 11.3% increase compared to 51.2 million euros ($65.2 million U.S.) during the first half of 2009. Nucletron attributed the results to growth in the brachytherapy market: Its product sales grew 27% compared to 2009.
The company also has appointed Peter Kingma as its new executive vice president of global sales and service. Kingma has held various positions at Siemens Healthcare of Malvern, PA, including global vice president of sales and marketing for CT in Germany and managing director in Australia and New Zealand. His last position with Siemens was vice president and business manager for the company's U.S. CT division.
Related Reading
Nucletron debuts Oncentra v4.0, July 20, 2010
Nucletron posts record 2009 earnings, May 26, 2010
Nucletron completes German order, May 24, 2010
Nucletron, ART add AccuBoost customer, May 17, 2010
Nucletron names Tarca to VP post, March 2, 2010
Copyright © 2010 AuntMinnie.com
